In a recently released analyst research report, Compass Point Research & Trading, LLC Managing Director and Senior Research Analyst covering the cannabis industry, Rommel Dionisio, initiated coverage on Curaleaf Holdings Inc. (CSE:CURA) (OTC:CURLF) with a buy rating and price target that suggests some huge upside to come.
This announcement comes just over a week after the U.S. multi-state cannabis operator completed its acquisition of the Emerald dispensary in Gilbert, Arizona.
Rommel Dionisio’s CURLF price target of $13.00 USD per share, equivalent to roughly $17.28 CAD per share implies a potential upside of approximately 70.16% based on the last traded price of $7.64 USD per share on the OTC markets.
Dionisio is one of three analysts hired to bolster the Equity Research Team at Compass Point Research & Trading, alongside Marshall Senk, and Jason Weaver.
According to a recent press release from Compass Point, “Mr. Dionisio joins Compass Point as a Managing Director and Senior Research Analyst covering the cannabis industry. Mr. Dionisio has over 23 years’ experience as a sell-side analyst covering consumer stocks, previously having worked at Merrill Lynch, FBR, and Wedbush Morgan. He is an eight-time honoree by the Thomson Reuters StarMine analyst ranking, a three-time All-Star on the Wall Street Journal’s Best of the Street annual survey, and a two-time honoree on Forbes’ Best Brokerage Analysts ranking. Mr. Dionisio received his BA and MBA degrees from Duke University.”
Be sure to subscribe to updates here so you never miss an important development.
Get Real-Time Updates from MJobserver.com